“X疾病”的研究与启示

樊忠胜, 桂婧, 谢泰, 刘晓荣

武警医学 ›› 2024, Vol. 35 ›› Issue (10) : 903-907.

PDF(1081 KB)
PDF(1081 KB)
武警医学 ›› 2024, Vol. 35 ›› Issue (10) : 903-907.
综述 

“X疾病”的研究与启示

  • 樊忠胜1, 桂婧2, 谢泰1, 刘晓荣1
作者信息 +
文章历史 +

摘要

全球化背景下,传染病特别是 “X疾病”具有生物安全威胁。根据世界卫生组织(WHO)的定义,“X疾病”指的是一种具有大流行潜力的未知病原体。本文回顾了中国生物安全法的实施情况,强调了生物安全对国家安全的重要性,并分析了全球众多生物安全事件(尤其是新型冠状病毒大流行)的影响,总结了 “X疾病”的来源,包括动物传染病、实验室泄漏和冰川融化,并提出了应对策略。这些战略包括加强国家应对公共卫生突发事件的能力、加强医疗和疫苗研发、利用先进的新技术进行疾病监测和控制、促进国际合作以及采用 “同一健康”概念。该文件探讨了应用新技术所面临的挑战,如数据安全和保护隐私,并强调在人口迁移时期需要加强对传染病的控制。这些综合措施旨在为应对未来可能出现的 “X疾病”大流行提供理论和实践建议。

关键词

X疾病 / 生物安全 / 公共卫生事件

引用本文

导出引用
樊忠胜, 桂婧, 谢泰, 刘晓荣. “X疾病”的研究与启示[J]. 武警医学. 2024, 35(10): 903-907
中图分类号: R186   

参考文献

[1] 贺福初, 高福锁. 生物安全:国防战略制高点[J]. 政工学刊, 2014(6):69-70.
[2] 朱水芳, 姜 帆. 国际生物安全发展趋势与对策初探[J]. 质量安全与检验检测, 2023,33(3):1-5.
[3] 钮 松. 总体国家安全体系、人类命运共同体与生物安全治理[J]. 国际关系研究, 2020(4):109-128.
[4] 全国人大常委会办公厅. 中华人民共和国生物安全法[M]. 中国民主法制出版社.
[5] 张冬梅, 姜世勃, 石正丽, 等. 关于新型冠状病毒命名的思考与建议[J]. 中国科技术语, 2020,22(2):5-10.
[6] Honigsbaum M. Disease X and other unknowns[J]. The Lancet, 2019,393(10180):1496-1497.
[7] Xia S,Yan L,Xu W,et al.A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike[J].Sci Found China, 2019,27(2):22.
[8] Jonkmans N, D'Acremont V, Flahault A. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases[J].BMJ Glob Health, 2021,6(9).
[9] Salmanton-García J, Wipfler P, Leckler J, et al. Predicting the next pandemic: vaccelerate ranking of the World Health Organization's blueprint for action to prevent epidemics[J]. Travel Med Infect Dis, 2024,57:102676.
[10] Roknuzzaman A S M,Aminul H M,Sabrina S,et al.The mysterious “Disease X” - a correspondence evaluating its public health threat, the global preparedness, and possible ways to avoid next pandemic[J].Int J Surg, 2023,60(11):100703.
[11] Gostin L.Living in an age of pandemics-from COVID-19 to monkeypox, polio, and disease X[J]. JAMA Health Forum, 2022,3(9):e224062.
[12] Islam A,Ferdous J,Islam S,et al.Transmission dynamics and susceptibility patterns of SARS-CoV-2 in domestic, farmed and wild animals: sustainable one health surveillance for conservation and public health to prevent future epidemics and pandemics[J].Transbound Emerg Dis,2022,69(5):2523-2543.
[13] Berezowski J,Balogh K,Dórea F C,et al.Prioritisation of zoonotic diseases for coordinated surveillance systems under the one health approach for cross-border pathogens that threaten the union[J].EFSA J, 2023,21(3):e07853.
[14] Gail H, Jonna M, Jonathan R, et al.What happens after Disease X: using one health to prevent the next pandemic[J].Nam Perspect,2020,2020(9).
[15] Manirambona E,Okesanya O J,Shomuyiwa D O,et al.Mitigating the threat of “Disease X” to global health security[J].New Microb New Infect,2024,57:101223.
[16] Chatterjee P, Nair P, Chersich M, et al.One Health, "Disease X" & the challenge of "Unknown" Unknowns[J]. Indian J Med Res,2021,153(3):264-271.
[17] 李大光.警惕生物安全威胁,全面维护生物安全[J]. 中国军转民, 2021(17):65-69.
[18] 孙 琳, 杨春华.美国近年生物恐怖袭击和生物实验室事故及其政策影响[J].军事医学,2017,41(11):923-928.
[19] 陈 拓, 张 威, 刘光琇, 等. 冰冻圈微生物:机遇与挑战[J]. 中国科学院院刊, 2020,35(4):434-442.
[20] 徐静阳, 张强弓, 施 一. 冰冻圈微生物演变与生物安全[J]. 中国科学院院刊, 2021,36(5):632-640.
[21] Ishrat M,Vinay G N,Arun S M, et al. Disease X: combating the next pandemic needs the nifty wastewater-based epidemiology tool[J]. Inter J Surg,2023,60:100701.
[22] Zaman M H,Ali N,Ilyas M.“Disease X” and prevention policies[J]. Front Public Heal, 2024,12:1303584.
[23] Van Kerkhove M D, Ryan M J, Ghebreyesus T A. Preparing for "Disease X"[J]. Science, 2021,374(6566):377.
[24] Christofferson R C, Cormier S A.Beyond the unknown: a broad framing for preparedness for emerging infectious threats[J]. Am J Trop Med Hyg, 2022,107(6):1159-1161.
[25] M S L, Vikramjit M. Special pathogens readiness in the United States: from ebola to Covid-19 to Disease X and beyond[J].Health Security, 2022,20(S1).
[26] Daniele M,Chiara M,Barbara B,et al. 'Disease X'-time to act now and prepare for the next pandemic threat[J]. Eur J Public Health,2022,32(6).
[27] Junaid T M, Imaduddin S, Yasir E M, et al.Disease X: a hidden but inevitable creeping danger[J].Infect Cont Hosp Ep, 2021,43(11):1-5.
[28] Tian Q, Han Z, Xue L L,et al. Disease X testing: the results of an international external quality assessment exercise[J]. J Biosafe Biosecur,2022,4(2):151-157.
[29] Simpson S,Kaufmann M C,Glozman V,et al.Disease X:accelerating the development of medical countermeasures for the next pandemic[J].Lancet Infect Dis,2020,20(5):e108-e115.
[30] Radanliev P,De Roure D,Maple C,et al. Methodology for integrating artificial intelligence in healthcare systems: learning from Covid-19 to prepare for Disease X[J].AI Ethics, 2022,2(4):623-630.
[31] Possas C, Marques E, Risi J J, et al. Covid-19 and future Disease X in circular economy transition: redesigning pandemic preparedness to prevent a global disaster[J].Circ Econ Sustain, 2021,1(4):1463-1478.
[32] Su Z, McDonnell D, Bentley B L, et al.Addressing biodisaster X threats with artificial intelligence and 6G technologies: literature review and critical insights[J].J Med Internet Res,2021,23(5):e26109.
[33] Nielsen B F,Sneppen K,Simonsen L.The counterintuitive implications of superspreading diseases[J].Nat Commun,2023,14(1):6954.
[34] Armitage R,Nellums L B. Disease X: availability bias, biotechnology and seeing beyond zoonotic risk[J]. Public Health, 2020,190.

PDF(1081 KB)

Accesses

Citation

Detail

段落导航
相关文章

/